Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
11.23 Up 0.34(3.12%) Jul 11, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2013Jun 30, 2012Jun 30, 2011
Total Revenue 35,535   16,357   19,305  
Cost of Revenue -   -   -  
Gross Profit 35,535   16,357   19,305  
Operating Expenses
Research Development87,073  69,192  63,453  
Selling General and Administrative21,471  20,422  16,040  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (73,009) (73,257) (60,188)
Income from Continuing Operations
Total Other Income/Expenses Net198  (62)1,914  
Earnings Before Interest And Taxes(72,811)(73,319)(58,274)
Interest Expense -   -   -  
Income Before Tax(72,811)(73,319)(58,274)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(72,811)(73,319)(58,274)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (72,811) (73,319) (58,274)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (72,811) (73,319) (58,274)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.